Celexa, Citalopram News Archives

Side-effects in doses cognitive deficits42. Administration: useless for the onset of Valium prescription.

Main Category: Depression Also Included In: Clinical Trials / Drug Trials ; Psychology / Psychiatry ; Mental Health Article Date: 17 Jul 2009 - 1:00 PDT Targacept, Inc.

Targacept, Inc. today announced positive top-line results from a double blind, placebo controlled, flexible dose Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder, or MDD, in subjects who did not respond adequately to first-line treatment with citalopram alone.

Targacept Inc. said yesterday that it has received positive results in the Phase 2b clinical trial of its drug TC-5214 as an augmentation therapy for major depressive disorder.

Shares of Targacept Inc. shot up a whopping 137 percent on news that TC-5214 hit its endpoints - bypassing expectations - in a Phase IIb study in major depressive disorder, giving the firm an edge in ongoing partnering discussions.

RCMP in Placentia/Whitbourne District are continuing an investigation of a break and enter into a private residence in the Jerseyside area over the weekend that resulted in the theft of prescription pills.